Intravenous Immunoglobulin (IVIG) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2934 | Report Format : | Status : Upcoming |

Abstract

Global Intravenous Immunoglobulin (IVIG) Market: Overview

Immunoglobulins (IGs) are basically glycoproteins generated in the blood plasma in reaction to the antigens, which are entirely foreign to the host system. They are extremely complex entities as well as explicit in their action. They are acquired from blood by fractionation method and are purified for both therapeutic as well as non-therapeutic applications. In therapeutics, they are majorly administered intravenously for the treatment of different deficiencies.

Global Intravenous Immunoglobulin (IVIG) Market: Growth Factors

The global intravenous immunoglobulin (IVIG) market is primarily driven by the augment in occurrences of hypogammaglobulinemia and chronic inflammatory demyelinating polyneuropathy and the increase in the usage of immunoglobulins to treat inflammatory myopathies, Guillain-Barre syndrome, specific antibody deficiency, and others. Further, the growth in approval of intravenous immunoglobulin (IVIG) drugs from European Medicine Agency (EMA), the Food and Drug Administration (FDA), and the government is projected to fuel the growth of the global intravenous immunoglobulin (IVIG) market.

Growth in aged population, as well as hemophilic patients, is likely to enhance IVIG production due to the appearance of developed technologies and improved purification methods (with better plasma production) are the other major aspects that contribute to the global intravenous immunoglobulin (IVIG) market growth. Furthermore, the market is likely to be restrained by the strict government regulations, the high price of therapy, as well as the risk of side effects related to the usage of IVIG.

Global Intravenous Immunoglobulin (IVIG) Market: Segmentation

The global intravenous immunoglobulin (IVIG) market is classified in terms of therapeutic area and plasma protein. The plasma protein division is further sub-divided into an albumin, polyvalent IVIg, factor IX and hyperimmune (IM&IV), and factor VIII. Polyvalent IVIg is expected to hold the maximum market share in the global intravenous immunoglobulin market. The therapeutic area division is segmented into autoimmune diseases, immune deficiencies, and acute infections. The immune deficiency division includes main diseases such as hypogammaglobulinemia (primary immune deficiencies), X-linked agammaglobulinemia, and obtain compromised immunity conditions (secondary immune deficiencies). The autoimmune disease division comprises inflammatory diseases and immune thrombocytopenia (ITP).

Global Intravenous Immunoglobulin (IVIG) Market: Regional Analysis

In terms of region, the global intravenous immunoglobulin (IVIG) market can be segmented into major regions such as Europe, Asia Pacific, Latin America, North America, and the Middle East & Africa. The global intravenous immunoglobulin (IVIG) market in North America is projected to reach a significant value and is also expected to grow at the highest rate in the coming future based on the demand. Advancements in technology, a wide range of products available, and growing number of patients with neurological and blood disorders are the most important growth factors of the North America intravenous immunoglobulin (IVIG) market. Although, Europe is anticipated to be the second most lucrative region on the basis of demand. The global market in the Asia Pacific will develop at a significant rate owing to its increased demand and requirement

Global Intravenous Immunoglobulin (IVIG) Market: Competitive Players

Some of the most important market players in the global intravenous immunoglobulin (IVIG) market are CSL Ltd., Baxter International Inc., Octapharma AG, Grifols S.A, LFB Group, Kedrion Biopharma Inc., China Biologics Products, Inc., Biotest AG, Bayer Healthcare., and BDI Pharma Inc., among others.

Global Intravenous Immunoglobulin (IVIG) Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Peptide and Anticoagulant Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3130 | Report Format:

Global Peptide and Anticoagulant Drugs Market: Overview Peptides anticoagulant drugs are likely to have a wide range of applications in treating several diseases for example osteoporosis, cancer, cardiovascular, diabetes, and coagulation disorders. Peptides are basically molecules that are univ...Read More

Crohn’s Disease Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3033 | Report Format:

Global Crohns Disease Market: Overview An inflammatory disease of bowel affecting any part of the Gastro-Intestinal Tract (GI Tract) is termed as Crohns disease. It is classified into a segment of chronic disease. Crohns disease is considered to impact nearly every part of an individuals life, a...Read More

Anti-Neoplastic Agents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3024 | Report Format:

Global Anti-Neoplastic Agents Market: Overview Anti-neoplastic agents are primarily used as a first-line treatment for cancer therapy as well as in combination with radiation or surgical therapy. A lot of anti-neoplastic agents are accessible commercially for the therapy of various kinds of canc...Read More

Kidney Fibrosis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-2989 | Report Format:

Global Kidney Fibrosis Treatment Market: Overview Fibrosis is the growth of extreme connective tissue owing to some injury or some disease. Disease in the kidney can cause kidney fibrosis. In this state, the kidneys fail to work properly which gradually leads to severe conditions. Kidney transpl...Read More

Oncology Based In-vivo CRO Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2982 | Report Format:

Global Oncology Based In-vivo CRO Market: Overview CRO basically stands for contract research organization which presents research services to a pharmaceutical, biotechnology, and medical devices key players on the basis of the contract. CRO offers services such as clinical research, biologic as...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.